These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6807667)

  • 1. Secondary hyperparathyroidism in X-linked hypophosphatemic mice.
    Kiebzak GM; Roos BA; Meyer RA
    Endocrinology; 1982 Aug; 111(2):650-2. PubMed ID: 6807667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. X-linked hypophosphatemic mice are not hypersensitive to parathyroid hormone.
    Kiebzak GM; Meyer RA
    Endocrinology; 1982 Mar; 110(3):1030-6. PubMed ID: 6276150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased plasma 1,25-dihydroxyvitamin D after low calcium challenge in X-linked hypophosphatemic mice.
    Meyer RA; Gray RW; Roos BA; Kiebzak GM
    Endocrinology; 1982 Jul; 111(1):174-7. PubMed ID: 6896304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the Hyp mutation and diet-induced hyperparathyroidism on renal parathyroid hormone- and forskolin-stimulated adenosine 3',5'-monophosphate production and brush border membrane phosphate transport.
    Tenenhouse HS; Veksler A
    Endocrinology; 1986 Mar; 118(3):1047-53. PubMed ID: 3004890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy.
    Meyer RA; Tenenhouse HS; Meyer MH; Klugerman AH
    J Bone Miner Res; 1989 Aug; 4(4):523-32. PubMed ID: 2816501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early lethality in Hyp mice with targeted deletion of Pth gene.
    Bai X; Miao D; Goltzman D; Karaplis AC
    Endocrinology; 2007 Oct; 148(10):4974-83. PubMed ID: 17615144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal parathyroid function in the X-linked hypophosphatemic mouse.
    Posillico JT; Lobaugh B; Muhlbaier LH; Drezner MK
    Calcif Tissue Int; 1985 Jul; 37(4):418-22. PubMed ID: 3930040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum insulin-like growth factor binding protein-3 in the hypophosphatemic mouse: decreased activity and abnormal modulation by dietary phosphate.
    Moriwake T; Abribat T; Brazeau P; Ecarot B
    J Bone Miner Res; 1995 Nov; 10(11):1698-704. PubMed ID: 8592946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence that low plasma 1,25-dihydroxyvitamin D causes intestinal malabsorption of calcium and phosphate in juvenile X-linked hypophosphatemic mice.
    Meyer RA; Meyer MH; Gray RW; Bruns ME
    J Bone Miner Res; 1987 Feb; 2(1):67-82. PubMed ID: 3455158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of different parathyroid hormone radioimmunoassays in uremic patients with secondary hyperparathyroidism.
    Togashi K; Takahashi N; Ando K; Tsukamoto Y; Marumo F
    Int J Artif Organs; 1990 Feb; 13(2):77-82. PubMed ID: 2347659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
    Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
    J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A role for the intestine in the bone disease of juvenile X-linked hypophosphatemic mice: malabsorption of calcium and reduced skeletal mineralization.
    Meyer MH; Meyer RA; Iorio RJ
    Endocrinology; 1984 Oct; 115(4):1464-70. PubMed ID: 6090101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-dependent release of N-terminal fragments and intact immunoreactive parathyroid hormone by human pathological parathyroid tissue in vitro.
    el-Hajj Fuleihan G; Chen CJ; Rivkees SA; Marynick SP; Stock J; Pallotta JA; Brown EM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):860-7. PubMed ID: 2778039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
    Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
    J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo Response of X-linked hypophosphatemic mice to calcitonin.
    Kiebzak GM; Meyer RA
    Horm Metab Res; 1982 Apr; 14(4):216-20. PubMed ID: 6282728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroid hormones increase renal brush border membrane transport of phosphate in X-linked hypophosphatemic (Hyp) mice.
    Kiebzak GM; Dousa TP
    Endocrinology; 1985 Aug; 117(2):613-9. PubMed ID: 4017950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumorous hyperparathyroidism in hypophosphatemic vitamin D--resistant rickets.
    Vincenti F; Hajjar ET; Salti IS
    J Med Liban; 1973; 26(6):583-94. PubMed ID: 4361307
    [No Abstract]   [Full Text] [Related]  

  • 19. Parathyroid hormone sensitivity in familial X-linked hypophosphatemic rickets.
    McElduff A; Posen S
    J Clin Endocrinol Metab; 1989 Aug; 69(2):386-9. PubMed ID: 2753981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered proximal tubule glucose metabolism in X-linked hypophosphatemic mice.
    Capparelli AW; Roh D; Dhiman JK; Jo OD; Yanagawa N
    Endocrinology; 1992 Jan; 130(1):328-34. PubMed ID: 1309337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.